1405 Research Blvd
Rockville, MD - 20850

Aeras News

Chinese study shows entecavir preventing hepatitus B in chemotherapy patients

In a recent study conducted at Sun Yat-sen University Cancer Center in China, researchers found that lymphoma patients undergoing chemotherapy getting the drug entecavir had a smaller incidence of acquiring hepatitis B. Read More »

Flublok vaccine touted as solution to new flu virus threat

There might be a solution in the wake of the Centers for Disease Control and Prevention's recent warning that the current influenza vaccine may not work this season after a new strain of the flu virus began circulating. Read More »

Study: Mouth bacteria may help with oral vaccine delivery

Scientists and researchers at the Forsyth Institute and Tufts University recently discovered that Streptococcus mitis, a common mouth bacteria, may help with oral vaccinations. Read More »

Researchers identify gene resistant to malaria treatment

Scientists recently discovered that the Plasmodium falciparum parasite (the parasite responsible for malaria) contains the single mutated gene (K13) responsible for increasing resistance to malaria treatments in Southeast Asia. Read More »

New research suggests MERS epidemic unlikely

Researchers recently performed new studies on Middle East respiratory syndrome coronavirus (MERS-CoV) and determined that it is unlikely MERS will become an epidemic. Read More »

Study finds flu virus, vaccine effect closely tied

A Swiss study released Thursday said how much protection the flu shot provides depends on how closely the vaccine matches the circulating virus. Read More »

Gavi aims to spend $300 million on Ebola vaccines for ravaged countries

Gavi, the Vaccine Alliance, said recently it plans to purchase and distribute millions of doses of an Ebola vaccine to support large-scale efforts in affected countries as soon as an effective vaccine is approved by the World Health Organization. Read More »

Researchers propose new dengue virus treatments

A team of researchers from the Julius Maximilian University of Wurzburg and the Johannes Gutenberg University Mainz in Germany recently proposed new treatment methods for dengue virus. Read More »

Flu vaccines increase immunity against multiple viruses

Researchers at St. Jude Children's Research Hospital recently found that seasonal flu vaccines may boost immune systems against multiple flu viruses and not just the viruses in the vaccine. Read More »

Study finds HPV vaccine has no effect on teen female sexual activity

Queen’s University researchers said their research indicates that the sexual behavior of teen girls is not impacted by the human papilloma virus vaccine. Read More »

Study: Injectable vaccines soon may fight cancer, deadly pathogens

Researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University and Harvard's School of Engineering and Applied Sciences (SEAS) recently discovered that a nonsurgical injection of biomaterial can potentially prevent and fight cancer and deadly infections such as HIV and Ebola. Read More »

Severe flu strains appear to be season's biggest threat

The Centers for Disease Control and Prevention (CDC) encourages all citizens to receive their influenza vaccines in light of the data predicting a severe flu season for 2014. Read More »

MRIGlobal awarded $3 million to create new HPV vaccine

The National Cancer Institute's PREVENT Cancer Program recently awarded MRIGlobal a $3 million contract to create and develop a vaccine for a human papillomavirus (HPV), which will be used in a future Phase I clinical trial. Read More »

Anti-malaria compound developed; human trials to begin

A team of international scientists led by researchers from St. Jude Children’s Hospital has discovered a compound that destroys malaria-infected red blood cells without harming healthy cells. Read More »

Study clarifies children at risk for influenza complications

Researchers at the University of Oxford called on the United States, United Kingdom and the World Health Organization recently to add children born prematurely to the priority group for the seasonal flu vaccine. Read More »

Australian researchers find potential new ways to combat malaria

Researchers from Australian National University (ANU) said recently that they discovered a slew of new chemicals with anti-malarial properties that may open the door to develop new drugs to fight the disease. Read More »

NC State researchers map human diseases

North Carolina State University researchers who recently mapped disease-causing pathogens found the world can theoretically be separated into seven regions for vectored human diseases spread by pests, such as malaria, and five regions for non-vectored diseases, such as cholera. Read More »

Aethlon reports positive results in Hepatitis C study

Aethlon Medical, Inc. said on Monday that its study conducted on Hepatitis C-infected individuals in India who received Hemopurifier therapy showed promise and the company is now set to start its first human clinical studies in the U.S. Read More »

STC to work with Alberta Health to control vaccine inventory

Management and distribution of vaccine supply, which can be extremely critical during a pandemic, outbreak, or in the event of a product recall, can be downright chaotic. Read More »

MERS-CoV study directed at health care workers

Greek researchers recently were able to identify gaps in infection control as a probable cause in all 11 known cases involving health care-associated transmission of Middle East respiratory syndrome coronavirus (MERS-CoV). Read More »